1616 A double blind, self-controlled randomized trial of prophylactic topical vitamin K1 cream application for cetuximab-related skin toxicity (VANQUISH trial). (September 2015) - Tsushima, T.; Yamazaki, K.; Kato, T.; Taku, K.; Yoshida, Y.; Hamauchi, S.; Yoshikawa, S.; Yagi, H.; Kimura, M.; Ishikawa, H.; Kimura, M.; Nakajo, M.; et al.